Sort
53,477 grants matching “addiction”
Adapt IFCBT into HIV Prevention Intervention
$391,180William W Latimer · Johns Hopkins University · R01 · FY2006 · DA
Oncogenic pathways and therapeutic targets in T cell acute lymphoblastic leukemia
$391,163David Michael Langenau · Massachusetts General Hospital · R01 · FY2018 · CA
Oncogenic pathways and therapeutic targets in T cell acute lymphoblastic leukemia
$391,163David Michael Langenau · Massachusetts General Hospital · R01 · FY2017 · CA
Oncogenic pathways and therapeutic targets in T cell acute lymphoblastic leukemia
$391,163David Michael Langenau · Massachusetts General Hospital · R01 · FY2021 · CA
Oncogenic pathways and therapeutic targets in T cell acute lymphoblastic leukemia
$391,163David Michael Langenau · Massachusetts General Hospital · R01 · FY2020 · CA
Identification of genes and genetic networks contributing to opioid use disorder traits in the Hybrid Rat Diversity Panel
$391,137Marissa A Ehringer · University Of Colorado · U01 · FY2024 · DA
PRECLINICAL DEVELOPMENT OF DRUGS FOR STIMULANT ABUSE
$391,129Georgia Institute Of Technology · R01 · FY2000 · DA
Training Program in Medications Development for Drugs of Abuse (Institutional Rut
$391,061Alexandros Makriyannis · Northeastern University · T32 · FY2009 · DA
Client and Counselor Attitudes Toward Medication
$391,057Oregon Health And Science University · R01 · FY2003 · DA
Transcriptional regulatory cascade of midbrain dopamine neuron development by Pit
$391,050Kwang-Soo Kim · Mclean Hospital · R01 · FY2011 · MH
Transcriptional regulatory cascade of midbrain dopamine neuron development by Pit
$391,050Kwang-Soo Kim · Mclean Hospital · R01 · FY2012 · MH
Morphine disrupts the regulation of neuronal function mediated by astrocyte exosomes
$391,028Norman J Haughey · Johns Hopkins University · R01 · FY2016 · DA
Dissection of Addiction Relevant Signal Integration by Cyfip2 through Precise Genome Engineering
$391,011Vivek Kumar · Jackson Laboratory · R33 · FY2024 · DA
LAB TRIALS TO DEVELOP MEDICATIONS FOR COCAINE DEPENDENCE
$390,962University Of Texas Hlth Sci Ctr San Ant · R01 · FY2003 · DA
Mechanisms of Probiotic Analgesia
$390,929David J Klumpp · Northwestern University At Chicago · R01 · FY2017 · AT
Design of Molecular Probes For Optical Imaging of Dopamine Neurotransmission
$390,928Dalibor Sames · Columbia Univ New York Morningside · R01 · FY2012 · MH
Ensemble activity in rat corticostriatal circuits during habit learning
$390,918Ann M Graybiel · Massachusetts Institute Of Technology · R01 · FY2015 · MH
Combined guanfacine and mindfulness meditation as an adjunct to buprenorphine maintenance in OUD
$390,895Suchismita Ray · Rutgers Biomedical And Health Sciences · R61 · FY2025 · DA
Magnetic Resonance, EEG, and Behavior After Cocaine
$390,856Marc J Kaufman · Mclean Hospital · R01 · FY2007 · DA
Computational neuroeconomic models of addiction: quantifying progression and treatment in opioid use disorder
$390,853Paul W Glimcher · New York University · R01 · FY2018 · DA
Anti-inflammatory therapy to improve outcomes in patients with chronic pancreatitis undergoing total pancreatectomy with islet autotransplant (TPIAT)
$390,847Melena D. Bellin · University Of Minnesota · R01 · FY2019 · DK
Anti-inflammatory therapy to improve outcomes in patients with chronic pancreatitis undergoing total pancreatectomy with islet autotransplant (TPIAT)
$390,847Melena D. Bellin · University Of Minnesota · R01 · FY2020 · DK
Excessive Alcohol Drinking Associated with GABA Alpha 2-Regulated TLR4 Expression
$390,822Harry L June · Howard University · R01 · FY2013 · AA
Cocaine-induced neuroplasticity: a new role for TGF beta signaling
$390,816David M Dietz · State University Of New York At Buffalo · R01 · FY2014 · DA
Alcohol Research Training: Methods & Mechanisms
$390,779Barbara S McCrady · University Of New Mexico · T32 · FY2015 · AA